Trial intelligence / Profile preview

Betadine before skin closure after caesarean section

ACTRN12611000379910Phase 4Completed

Sponsor
KMT
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of povidone-iodine in surgical site infection (SSI) (2 arms), sponsored by KMT. Primary endpoint: Wound infection within 6 weeks of delivery. Started Apr 2010; status: completed.

02

Drugs

povidone-iodine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on ACTRN12611000379910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12611000379910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call